Retinopathy of Prematurity Market Analysis

  • Report ID: 5823
  • Published Date: Nov 28, 2025
  • Report Format: PDF, PPT

Retinopathy of Prematurity Market Segmentation:

Disease Type Segment Analysis

The partial retinal detachment segment in the retinopathy of prematurity market is estimated to gain the largest revenue share of about 56% in the year 2035. The segment growth can be attributed to factors that rise in cases of partial retinal detachment may necessitate specialized surgical procedures for effective treatment. This could lead to growth in the market for surgical equipment and expertise related to retinopathy of prematurity management. In addition, the diagnosis of partial retinal detachment in retinopathy of prematurity often requires advanced imaging technologies expertise which leads to demand for diagnostic tools that further stimulate segment growth.

End-User Segment Analysis

The hospital segment is estimated to gain the largest market share of about 54% in the year 2035. The segment growth can be attributed to education provided by hospitals to caregivers about retinopathy of prematurity, its risk factors, and the importance of regular eye examinations for premature infants. In addition, hospitals become central in providing various treatment modalities related to retinopathy of prematurity and employ skilled healthcare professionals to carry out the interventions that stimulate segment growth. According to the National Library of Medicine, the incidence of retinopathy of prematurity ranges from 17% in the public hospital to 30% in private hospitals. About 4% preterm babies require treatment for retinopathy of prematurity.

Our in-depth analysis of the global market includes the following segments:

          Disease Type

  • Partial Retinal Detachment
  • Extra-Retinal Fibrovascular Proliferation
  • Total Retinal Detachment

          End-User

  • Hospitals
  • Clinic
  • Home Care

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of retinopathy of prematurity is estimated at USD 10.38 million.

The global retinopathy of prematurity market size was over USD 9.91 million in 2025 and is anticipated to witness a CAGR of around 5.3%, crossing USD 16.61 million revenue by 2035.

Across 2026–2035, the North America retinopathy of prematurity market is expected to secure a 41% share by 2035, bolstered by continuous medical technology advancements, stronger early-detection efforts, and rising adoption of AI-enabled neonatal diagnostic tools.

Key players in the market include Visunex Medical System, Merge Healthcare, Natus Medical Incorporated, Servicom Medical, Advancing Eyecare, Insmed Inc, Alimera Sciences Inc., Biomar Microbial Technologies, Regeneron Pharmaceuticals, Hoffmann-La-Rochelnc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos